ZA201301795B - Inhibitors of notum pectinacetylesterase and methods of their use - Google Patents
Inhibitors of notum pectinacetylesterase and methods of their useInfo
- Publication number
- ZA201301795B ZA201301795B ZA2013/01795A ZA201301795A ZA201301795B ZA 201301795 B ZA201301795 B ZA 201301795B ZA 2013/01795 A ZA2013/01795 A ZA 2013/01795A ZA 201301795 A ZA201301795 A ZA 201301795A ZA 201301795 B ZA201301795 B ZA 201301795B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitors
- methods
- notum pectinacetylesterase
- pectinacetylesterase
- notum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38252610P | 2010-09-14 | 2010-09-14 | |
| PCT/US2011/051421 WO2012037141A1 (en) | 2010-09-14 | 2011-09-13 | Inhibitors of notum pectinacetylesterase and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201301795B true ZA201301795B (en) | 2014-05-28 |
Family
ID=44678054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2013/01795A ZA201301795B (en) | 2010-09-14 | 2013-03-08 | Inhibitors of notum pectinacetylesterase and methods of their use |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20120065200A1 (en) |
| EP (1) | EP2616471B1 (en) |
| JP (1) | JP2013537202A (en) |
| KR (1) | KR20130112888A (en) |
| CN (1) | CN103328481A (en) |
| AR (1) | AR082968A1 (en) |
| AU (1) | AU2011302225A1 (en) |
| BR (1) | BR112013006131A2 (en) |
| CA (1) | CA2811005A1 (en) |
| CL (1) | CL2013000682A1 (en) |
| CO (1) | CO6710916A2 (en) |
| DK (1) | DK2616471T3 (en) |
| ES (1) | ES2536078T3 (en) |
| MX (1) | MX2013002851A (en) |
| NZ (1) | NZ608031A (en) |
| PL (1) | PL2616471T3 (en) |
| PT (1) | PT2616471E (en) |
| RU (1) | RU2013116801A (en) |
| SG (1) | SG188530A1 (en) |
| TW (1) | TW201219401A (en) |
| WO (1) | WO2012037141A1 (en) |
| ZA (1) | ZA201301795B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012012712A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Tricyclic proteasome activity enhancing compounds |
| AR090037A1 (en) * | 2011-11-15 | 2014-10-15 | Xention Ltd | DERIVATIVES OF TIENO AND / OR FURO-PYRIMIDINES AND PYRIDINES INHIBITORS OF THE POTASSIUM CHANNELS |
| JP2015504919A (en) | 2012-01-25 | 2015-02-16 | プロテオステイシス セラピューティクス，インコーポレイテッド | Compounds that modulate proteasome activity |
| AU2017388054B2 (en) | 2016-12-28 | 2022-03-24 | Dart Neuroscience, Llc | Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors |
| CA3120971A1 (en) | 2017-11-27 | 2019-05-31 | Dart Neuroscience, Llc | Substituted furanopyrimidine compounds as pde1 inhibitors |
| GB201814151D0 (en) * | 2018-08-31 | 2018-10-17 | Ucl Business Plc | Compounds |
| CN111171044B (en) * | 2018-11-13 | 2022-06-24 | 沈阳化工研究院有限公司 | Thienopyrimidine compound and medical application thereof |
| JP7458406B2 (en) | 2018-12-21 | 2024-03-29 | セルジーン コーポレーション | Thienopyridine inhibitor of RIPK2 |
| JP2022526901A (en) | 2019-03-19 | 2022-05-27 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | Anthelmintic azabenzothiophene and azabenzofuran compounds |
| US11827629B2 (en) | 2021-05-27 | 2023-11-28 | National Health Research Institutes | CDGSH iron sulfur domain 2 activators and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4008726A1 (en) | 1990-03-19 | 1991-09-26 | Basf Ag | Thieno-(2,3-D)pyrimidine derivs. - are plant growth regulators, herbicides and pesticides, esp. insecticides |
| US6080576A (en) | 1998-03-27 | 2000-06-27 | Lexicon Genetics Incorporated | Vectors for gene trapping and gene activation |
| US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
| RU2009100159A (en) * | 2006-06-12 | 2010-07-20 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | THIENOPYRAMIDINES USEFUL AS ION CHANNEL MODULATORS |
| WO2009001214A2 (en) * | 2007-06-28 | 2008-12-31 | Pfizer Products Inc. | Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists |
-
2011
- 2011-09-08 TW TW100132460A patent/TW201219401A/en unknown
- 2011-09-13 KR KR1020137009332A patent/KR20130112888A/en not_active Application Discontinuation
- 2011-09-13 SG SG2013018700A patent/SG188530A1/en unknown
- 2011-09-13 MX MX2013002851A patent/MX2013002851A/en not_active Application Discontinuation
- 2011-09-13 WO PCT/US2011/051421 patent/WO2012037141A1/en active Application Filing
- 2011-09-13 PT PT117612069T patent/PT2616471E/en unknown
- 2011-09-13 BR BR112013006131A patent/BR112013006131A2/en not_active IP Right Cessation
- 2011-09-13 AU AU2011302225A patent/AU2011302225A1/en not_active Abandoned
- 2011-09-13 RU RU2013116801/04A patent/RU2013116801A/en not_active Application Discontinuation
- 2011-09-13 DK DK11761206.9T patent/DK2616471T3/en active
- 2011-09-13 JP JP2013528388A patent/JP2013537202A/en not_active Withdrawn
- 2011-09-13 CN CN2011800442957A patent/CN103328481A/en active Pending
- 2011-09-13 NZ NZ608031A patent/NZ608031A/en not_active IP Right Cessation
- 2011-09-13 PL PL11761206T patent/PL2616471T3/en unknown
- 2011-09-13 ES ES11761206.9T patent/ES2536078T3/en active Active
- 2011-09-13 EP EP11761206.9A patent/EP2616471B1/en not_active Not-in-force
- 2011-09-13 CA CA2811005A patent/CA2811005A1/en not_active Abandoned
- 2011-09-13 US US13/231,653 patent/US20120065200A1/en not_active Abandoned
- 2011-09-13 AR ARP110103323A patent/AR082968A1/en unknown
-
2013
- 2013-03-08 ZA ZA2013/01795A patent/ZA201301795B/en unknown
- 2013-03-13 CL CL2013000682A patent/CL2013000682A1/en unknown
- 2013-04-12 CO CO13094694A patent/CO6710916A2/en not_active Application Discontinuation
-
2014
- 2014-06-10 US US14/300,281 patent/US20140288071A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011302225A1 (en) | 2013-03-21 |
| MX2013002851A (en) | 2013-05-28 |
| CA2811005A1 (en) | 2012-03-22 |
| US20140288071A1 (en) | 2014-09-25 |
| CL2013000682A1 (en) | 2013-11-08 |
| CO6710916A2 (en) | 2013-07-15 |
| PT2616471E (en) | 2015-04-20 |
| AR082968A1 (en) | 2013-01-23 |
| SG188530A1 (en) | 2013-04-30 |
| DK2616471T3 (en) | 2015-04-07 |
| PL2616471T3 (en) | 2015-07-31 |
| BR112013006131A2 (en) | 2016-06-07 |
| CN103328481A (en) | 2013-09-25 |
| TW201219401A (en) | 2012-05-16 |
| JP2013537202A (en) | 2013-09-30 |
| EP2616471B1 (en) | 2014-12-31 |
| EP2616471A1 (en) | 2013-07-24 |
| WO2012037141A1 (en) | 2012-03-22 |
| KR20130112888A (en) | 2013-10-14 |
| RU2013116801A (en) | 2014-10-20 |
| ES2536078T3 (en) | 2015-05-20 |
| NZ608031A (en) | 2015-01-30 |
| US20120065200A1 (en) | 2012-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2616442B8 (en) | Inhibitors of pi3k-delta and methods of their use and manufacture | |
| HK1213769A1 (en) | Arginase inhibitors and methods of use thereof | |
| IL222227A0 (en) | Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use | |
| EP2678018A4 (en) | Combination of kanase inhibitors and uses thereof | |
| EP2536756A4 (en) | Hsa-related compositions and methods of use | |
| EP2584897A4 (en) | Resveratrol-containing compositions and methods of use | |
| EP2539005A4 (en) | Mouthpiece and methods of use of same | |
| SG11201504022RA (en) | Glutamase inhibitors and method of use | |
| EP2571421A4 (en) | Detection devices and related methods of use | |
| ZA201207937B (en) | Sarms and method of use thereof | |
| EP2675471A4 (en) | Hsa-related compositions and methods of use | |
| EP2536283A4 (en) | Phenyl-heteroaryl derivatives and methods of use thereof | |
| ZA201401653B (en) | Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use | |
| EP2579831A4 (en) | Dispenser and methods of use | |
| ZA201301795B (en) | Inhibitors of notum pectinacetylesterase and methods of their use | |
| EP2596112A4 (en) | Acetycysteine compositions and methods of use thereof | |
| HK1201463A1 (en) | Cd40l-specific tn3-derived scaffolds and methods of use thereof cd40l- tn3- | |
| EP2464227A4 (en) | Compounds and methods of use thereof | |
| EP2536709A4 (en) | Prolylhydroxylase inhibitors and methods of use | |
| IL257069B (en) | Inhibitors of apoptosis and uses thereof | |
| EP2709999A4 (en) | Quinazoline-7-ether compounds and methods of use | |
| EP2611791A4 (en) | Oligooxopiperazines and methods of making and using them | |
| ZA201303855B (en) | Benzoxazepines as inhibitors of p13k/m tor and methods of their use and manufacture | |
| ZA201303757B (en) | Benzoxazepines as inhibitors of mtor and methods of their use and manufacture | |
| GB2478317B (en) | Herbicidal composition and method of use thereof |